biowa,
Nice news release..>)
Wednesday December 29, 4:47 pm Eastern Time
Company Press Release
SOURCE: NPS Pharmaceuticals, Inc.
Core Receptor Technology Patents Awarded to NPS Pharmaceuticals
SALT LAKE CITY, Dec. 29 /PRNewswire/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP - news; Toronto: NX - news) announced today the issuance and notices of allowance of 14 U.S. patents and patent applications received from the United States Patent and Trademark Office (USPTO). Together, this group of patents defines a cohesive and large body of intellectual property focused on the calcium receptor (CaR) and the related family of metabotropic glutamate receptors (mGluRs). This core technology, in turn, is the basis for several major NPS programs, partnered and proprietary. The partnered programs include hyperparathyroidism (HPT) and osteoporosis, while the proprietary programs address disorders such as pain, epilepsy, anxiety, psoriasis, and diabetes.
(Photo: newscom.com )
<SNIP>
biz.yahoo.com
Enjoy!
Walter |
